ATS 2019 Virtual Final Program

CLINICAL ADULT CLINICAL CORE CURRICULUM CME Credits Available: 2 MOC Points Available: 2 CC3 PULMONARY CLINICAL CORE CURRICULUM II. 2:15 p.m. - 4:15 p.m. KBHCCD Hall A (Level 2) Target Audience Practicing internists, subspecialists, registered nurses and advanced practice nurses in pulmonary, critical care, and sleep medicine who work in a clinical setting and are currently engaged in maintenance of certification Objectives At the conclusion of this session, the participant will be able to: • remain current with medical knowledge relevant to their practice in pulmonary, critical care, and sleep medicine; • evaluate their understanding of key skills and content areas in pulmonary, critical care and sleep medicine, as well as receive feedback on their comprehension of a result of a pre-test/post-test comparison; • support clinicians who are engaged in maintenance of certification activities by providing updates on subjects included in recertification requirements. The ATS Clinical Core Curriculum Symposia focus on a 3-year content cycle of key medical content in the areas of Pulmonary, Critical Care, and Sleep Medicine. The topics are also aligned with corresponding MOC Medical Knowledge modules. This symposium is intended to assist clinicians with staying current with the growth of information relevant to their medical practice, as well as provide an opportunity to evaluate individual knowledge and skills while earning MOC Medical Knowledge points. Chairing: C.L. Channick, MD, Los Angeles, CA T.J. Huie, MD, Denver, CO 2:15 The Evaluation and Management of Adult Bronchiolitis S. Callahan, MD, Salt Lake City, UT 2:45 Updates in Bronchiectasis P.J. McShane, MD, Chicago, IL 3:15 Approach to Eosinophilic Lung Disease P. Akuthota, MD, La Jolla, CA 3:45 Lung Transplant in Patients with Obstructive Lung Disease L. Frye, MD, Chicago, IL This session and the International Conference are supported by educational grants from Genentech, Inc., Insmed Incorporated, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. ATS 2019 • Dallas, TX MONDAY • MAY 20 197 MONDAY MID-DAY Monday Afternoon, May 20 2:15 p.m. - 4:15 p.m. PRESENTATION OF THE RECOGNITION AWARDS FOR SCIENTIFIC ACCOMPLISHMENTS KBHCCD Ballroom A Three (Level 2) As part of the ATS Respiratory Health Awards, the Recognition Awards for Scientific Accomplishments is given to individuals for outstanding scientific contributions in basic or clinical research to the understanding, prevention and treatment of lung disease. Those considered for the award are recognized for either scientific contributions throughout their careers or for major contributions at a particular point in their careers. Chairing : A.J. Halayko, PhD, ATSF, Winnipeg, Canada M. Moss, MD, ATSF, Aurora, CO Awardees: 2:15 Surfactant Protein A Genetic Variants: So What? Interplay of Genetic Variability, Sex, and Oxidative Stress Joanna Floros, PhD, ATSF, Hershey, PA 2:45 Respiratory Infections and Asthma: The Role of the Microbiome Nicholas W. Lukacs, PhD, Ann Arbor, MI 3:15 Infection and Immunity in the Lung Prabir Ray, PhD, Pittsburgh, PA 3:45 Lung Innate Immunity: From Chemokines to Toll Receptors and Beyond Theodore J. Standiford, MD, Ann Arbor, MI 1:15 p.m. - 2:15 p.m VISIT THE EXHIBIT HALL Take this opportunity between sessions to visit the Exhibit Hall to gain practical knowledge to advance care and research. Exhibitors will be on hand to provide information on pharmaceutical products, medical equipment, publications and research services.